Price List Femlyv - Contraceptive Agents - Multiple.xlsx

XLSX spreadsheet 46 KB Posted

Attached to
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Solicitation number
HT9402-24-Q-9404
Issued by

About this file

This document is a Price List and Blanket Purchase Agreement Appendix related to a Department of Defense (DoD) Uniform Formulary contract opportunity for Contraceptive Agents. The DoD Pharmacy and Therapeutics Committee will review newly approved drugs, including Femlyv, at their November 2024 meeting. The DoD is seeking quotes from industry for the placement of these drugs on the Uniform Formulary, including pricing, discount, and refund information. Quotes are due by October 16, 2024, and the DoD may award Uniform Formulary Blanket Purchase Agreements and Additional Discount Program Agreements based on the Uniform Formulary decisions. The document provides pricing templates for 10 newly approved Contraceptive Agent drugs across various formulary scenarios, package sizes, and pricing models including Federal Ceiling Price and Wholesale Acquisition Cost discounts.

View the file

Other files

Show all 12

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

BPA

UF BPA NDC Price List for the November 2024 DoD P&T Meeting
DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
Formulary Notes
Class Note(s): Prior Authorization may apply.

Step Therapy Addendum: N/A

Notes to Manufacturers: Do not forget to submit fully executed signature pages along with quote information.

The price per unit of measure for a given dosage form and strength (each, gram, mL, etc.) of the pharmaceutical agent will be the same for all available package sizes (e.g., 30s, 100s, 1000s) within a given dispensing venue.

Blanket Purchase Agreement Appendix – Newly Approved Drug

#1DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#2DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#3DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#4DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#5DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#6DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#7DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#8DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#9DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#10DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

ADP (non-FAMP Discount)

UF ADP Appendix for the November 2024 DoD P&T Meeting
DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
Formulary Notes
Class Note(s): Prior Authorization may apply.

Notes to Manufacturers: Do not forget to submit fully executed signature pages along with quote information.

* Total Calculated Refund Per FCP is calculated as: ((non-FAMP-FCP)+(non-FAMP*Y%)) = Total Calculated Refund **Based on the most recent annual non-FAMP (reported to the Department of Veterans Affairs) from which the current annual Federal Ceiling Price (FCP) calculated ceiling is derived. The current annual FCP and the annual non-FAMP from which it is derived will be applicable to all prescriptions filled during a calendar year. The quoted additional refund percentage will remain static during the life of the agreement but the most recent annual non-FAMP, and thus the calculated refund, may change each calendar year.

Additional Discount Program Appendix – Newly Approved Drug

#1DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#2DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#3DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#4DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#5DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#6DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#7DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#8DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#9DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#10DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

ADP (WAC Discount)

UF ADP Appendix for the November 2024 DoD P&T Meeting
DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
Formulary Notes
Class Note(s): Prior Authorization may apply.

Notes to Manufacturers: Do not forget to submit fully executed signature pages along with quote information.

The Wholesale Acquisition Cost (WAC) is obtained from First Databank via daily price updates; it is maintained at the dispensing unit level to five (5) decimal places. If the WAC changes during a calendar quarter, an average WAC will be calculated on a daily weighted basis (per unit only).

WAC is ONLY used for products that do not have a FCP, such as diabetic supplies (i.e., test strips), and can also be applied to covered drugs.

*The quoted WAC Discount percentage will remain static during the life of the agreement.

Additional Discount Program Appendix – Newly Approved Drug

#1DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#2DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#3DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#4DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#5DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#6DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#7DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#8DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#9DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#10DOD Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 6-7, 2024
DOD Uniform Formulary Subclass:MULTIPLEQuotes due:October 16, 2024
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

File details come from the government source that posted it. Updated .